Works matching IS 14712407 AND DT 2018 AND VI 18 AND IP 1


Results: 948
    1
    2
    3
    4

    Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.

    Published in:
    2018
    By:
    • Ettrich, Thomas J.;
    • Berger, Andreas W.;
    • Perkhofer, Lukas;
    • Daum, Severin;
    • König, Alexander;
    • Dickhut, Andreas;
    • Wittel, Uwe;
    • Wille, Kai;
    • Geissler, Michael;
    • Algül, Hana;
    • Gallmeier, Eike;
    • Atzpodien, Jens;
    • Kornmann, Marko;
    • Muche, Rainer;
    • Prasnikar, Nicole;
    • Tannapfel, Andrea;
    • Reinacher-Schick, Anke;
    • Uhl, Waldemar;
    • Seufferlein, Thomas
    Publication type:
    journal article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50